Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.2461
-0.0018 (-0.73%)
Aug 6, 2025, 3:59 PM EDT
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of $368.08 million as of August 6, 2025. Its market cap has decreased by -22.50% in one year.
Market Cap
368.08M
Enterprise Value
448.95M
Revenue
1.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.25
Market Cap Chart
Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 368.08M, an increase of 3,477.34%. That is a compound annual growth rate of 16.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 368.08M | 1.13% |
| Dec 31, 2024 | 363.95M | -55.71% |
| Dec 29, 2023 | 821.84M | -1.00% |
| Dec 30, 2022 | 830.10M | 25.14% |
| Dec 31, 2021 | 663.34M | -47.13% |
| Dec 31, 2020 | 1.25B | 870.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 575.48M |
| Glass House Brands | 474.59M |
| American Oncology Network | 330.70M |
| CytoDyn | 328.46M |
| Alterola Biotech | 296.25M |